Principal components analysis of brain metabolism predicts development of Alzheimer dementia

G Blazhenets, Y Ma, A Sörensen… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The value of 18F-FDG PET for predicting conversion from mild cognitive impairment (MCI) to
Alzheimer dementia (AD) is currently under debate. We used a principal components …

[HTML][HTML] Potential clinical value of multiparametric PET in the prediction of Alzheimer's disease progression

X Chen, Y Zhou, R Wang, H Cao, S Reid, R Gao… - PLoS …, 2016 - journals.plos.org
Objective To evaluate the potential clinical value of quantitative functional FDG PET and
pathological amyloid-β PET with cerebrospinal fluid (CSF) biomarkers and clinical …

A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer's disease in a clinical setting

L Iaccarino, K Chiotis, P Alongi… - Journal of …, 2017 - content.iospress.com
Assessments of brain glucose metabolism (18F-FDG-PET) and cerebral amyloid burden
(11C-PiB-PET) in mild cognitive impairment (MCI) have shown highly variable performances …

[HTML][HTML] Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data

A Sörensen, G Blazhenets, G Rücker, F Schiller… - NeuroImage: Clinical, 2019 - Elsevier
Aim The value of 18 F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from
mild cognitive impairment (MCI) to Alzheimer's dementia (AD) is controversial. In the present …

Visual rating and computer-assisted analysis of FDG PET in the prediction of Conversion to Alzheimer's disease in mild cognitive impairment

JM Kang, JY Lee, YK Kim, BK Sohn, MS Byun… - Molecular Diagnosis & …, 2018 - Springer
Background Fluorodeoxyglucose (FDG) positron emission tomography (PET) is useful to
predict Alzheimer's disease (AD) conversion in patients with mild cognitive impairment …

[HTML][HTML] Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Amyloid PET and Brain MR Imaging Data: A 48-Month Follow-Up …

DH Kim, M Oh, JS Kim - Diagnostics, 2023 - mdpi.com
We developed a novel quantification method named “shape feature” by combining the
features of amyloid positron emission tomography (PET) and brain magnetic resonance …

Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

J Arbizu, E Prieto, P Martínez-Lage… - European journal of …, 2013 - Springer
Purpose To introduce, evaluate and validate a voxel-based analysis method of 18 F-FDG
PET imaging for determining the probability of Alzheimer's disease (AD) in a particular …

[HTML][HTML] Monitoring alzheimer's disease progression in mild cognitive impairment stage using machine learning-based FDG-PET classification methods

I Beheshti, N Geddert, J Perron, V Gupta… - Journal of …, 2022 - content.iospress.com
Background: We previously introduced a machine learning-based Alzheimer's Disease
Designation (MAD) framework for identifying AD-related metabolic patterns among …

Comparison of Neuroimaging Modalities for the Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Dementia

P Trzepacz, P Yu, J Sun, K Schuh… - … American journal of …, 2013 - Am Assoc Geria Psych
Methods We analyzed ADNI 1 data available as of Aug. 2011. A total of 29 numeric
variables were considered, comprising both region of interest (ROI) and composite imaging …

Principal-component analysis–based measures of PET data closely reflect neuropathologic staging schemes

G Blazhenets, L Frings, A Sörensen… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Voxel-based principal-component analysis allows for an identification of patterns of glucose
metabolism and amyloid deposition related to the conversion from mild cognitive impairment …